SGLT2 inhibitors for paediatric heart failure: time for innovative trials

Int J Cardiol. 2025 Nov 1:438:133521. doi: 10.1016/j.ijcard.2025.133521. Epub 2025 Jun 20.
No abstract available

Keywords: Child; Dapagliflozin; Empagliflozin; Heart failure; Modeling and simulation; Pharmacokinetics; Trial.

Publication types

  • Editorial